You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The government says it is using DNA testing as part of efforts to reunite families by court-ordered deadlines, but it will not reveal which lab is performing testing.
HHS may already be administering DNA testing to migrant families, but the agency has provided little information about how testing is being implemented.
The project will investigate the use of whole-genome sequencing within the California Medical Assistance program.
The subcommittee called for $2 billion to be added to the NIH's budget next year, increasing it to $39.1 billion.
Seventeen organizations don't support the Diagnostic Accuracy and Innovation Act as written and would like lawmakers to advance a CLIA-centric framework.
The proposed bill would increase the National Institutes of Health's budget from roughly $37.1 billion to $38.3 billion in fiscal 2019.
After the arrest of the Golden State Killer, ethicists say the government must delineate acceptable limits for future uses of public DNA databases.
The plan seeks to modernize the US biomedical data handling infrastructure, in order to to keep up with the explosive growth in information from genomics research.
A Veterans Health Administration subcommittee evaluated the clinical utility of 30 pharmacogenetic tests and recommended about half for wider use.
A panel at the Biology of Genomes meeting discussed the ethical, legal, and social ramifications of germline gene editing.
The agency asked Reps. Bucshon and DeGette to consider the precertification program idea as they work on refining the draft of the Diagnostic Accuracy and Innovation Act.
Critics worry that without appropriate safeguards, DNA phenotyping will lead to discrimination while supporters see it as a tool to help investigate crimes.
President Trump had earlier in the day said on Twitter that he was considering vetoing the bill over an immigration issue and a lack of funding for a proposed Mexican border wall.
Increasing NIH funding has been a priority for Congress in recent years, despite calls from the White House to trim the agency's budget.
These lobbying efforts aim to shore up willingness among legislators to step in and halt implementation of the NCD if certain provisions remain in the final version.
At the ACLA conference this week, FDA Commissioner Gottlieb outlined his vision for the agency in the realm of LDTs.
The bill aims to reduce barriers to the use of genetic and genomic testing, including for children on Medicaid with a suspected genetic disease.
While the President's budget proposal would slash the NIH's budget by 27 percent, the White House is seeking additional funding to bring the agency's budget to its 2017 level.
The spending deal comes amid efforts by lawmakers to avoid another government shutdown, and includes lifting the national debt limit through March 1, 2019.
The registry from the American Society for Clinical Pathology aims to eventually collect metrics on how lab services impact patient outcomes.
The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.
According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.
CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.
In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.